Prescription medicines
Astellas develops and sells branded prescription drugs for use in hospitals, clinics, and pharmacies, with products in urology, oncology, immunology and transplant care, and eye care.
Customers and revenue model
Astellas Pharma Inc
F:YPHA
Astellas Pharma Inc
F:YPHA
Price:
14.6
EUR
6.57%
Market Closed
Market Cap:
€26.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
M
|
Memphasys Ltd
ASX:MEM
|
AU |
|
H
|
Helmerich and Payne Inc
SWB:HPC
|
US |
|
Polytec Holding AG
LSE:0GOX
|
AT |
|
V
|
Volkswagen AG
XHAM:VOW3
|
DE |
|
Atlassian Corp
NASDAQ:TEAM
|
AU |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
C
|
China Everbright Ltd
XMUN:EVI
|
HK |
|
C
|
Coca-Cola HBC AG
OTC:CCHBF
|
CH |
|
S
|
Shanghai Industrial Urban Development Group Ltd
OTC:SIUDF
|
HK |
|
Ocean Sun AS
F:OW7
|
NO |
|
B
|
Bankware Global Co Ltd
KOSDAQ:199480
|
KR |
|
ANZ Group Holdings Ltd
F:X5Z
|
AU |
|
I
|
Interactive Brokers Group Inc
SWB:KY6
|
US |
|
O
|
Orron Energy AB
DUS:LYV
|
SE |
|
S
|
Sunflag Iron and Steel Co Ltd
BSE:500404
|
IN |
|
B
|
Brimstone Investment Corporation Ltd
JSE:BRT
|
ZA |
|
Bitcoin Group SE
XETRA:ADE
|
DE |
|
Banco Bradesco SA
BOVESPA:BBDC4
|
BR |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
|
D
|
Daimler Truck Holding AG
XMUN:DTG
|
DE |
|
G
|
GR Silver Mining Ltd
F:GPE
|
CA |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
D
|
Daimler Truck Holding AG
DUS:DTG
|
DE |
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Headquarters
- Japan JP
- Employees
- 13 643
- IPO date
- May 16, 1949
Astellas Pharma is a Japanese drug company that discovers, develops, makes, and sells prescription medicines. Its main products treat areas such as urology, transplant medicine, immunology, cancer, and eye disease. The company spends heavily on research and then brings branded drugs through testing, approval, manufacturing, and distribution.
Its main customers are doctors, hospitals, pharmacies, and healthcare systems that prescribe or buy medicines for patients. Astellas makes money mostly by selling prescription drugs, along with income from licensing and partnership deals when it shares technology or rights to certain medicines with other drugmakers.
What makes Astellas different is that it sits in the high-value part of the pharmaceutical chain: it turns scientific research into approved medicines for specific diseases. That means its business depends less on high-volume commodity sales and more on a smaller number of branded treatments that are protected by patents and supported by medical data.
Continue YPHA Research
Other Astellas Pharma Inc listings:
